2025-01-22 13-14-13

Content

References

Original Sources1Citations
vanrijtEnantiomerspecificPharmacokineticsDL3hydroxybutyrate2021Rijt, Willemijn J. van, Johan L. K. Van Hove, Frédéric M. Vaz, Rick Havinga, Derk P. Allersma, Tanja R. Zijp, Jirair K. Bedoyan, et al. “Enantiomer‐specific Pharmacokinetics of D,L‐3‐hydroxybutyrate: Implications for the Treatment of Multiple acyl‐CoA Dehydrogenase Deficiency.” Journal of Inherited Metabolic Disease 44, no. 4 (July 2021): 926–38. https://doi.org/10.1002/jimd.12365.